Bell Investment Advisors’s Avidity Biosciences RNAM Stock Holding History

Bell Investment Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40	Closed	-$2.89K	–	1927
2025 Q4	$2.89K	Buy	40 +14	+54%	+$904	﹤0.01%	1213
2025 Q3	$1.13K	Hold	26	–	–	﹤0.01%	1527
2025 Q2	$739	Buy	+26	New	+$775	﹤0.01%	1676

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Bell Investment Advisors's RNAM Position: Q1 2026 in Review

Bell Investment Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 40 shares — an estimated $2.89K sold.

Bell Investment Advisors first reported a position in RNAM in Q2 2025 and held it in 3 quarters. The position peaked at $2.89K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Bell Investment Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Bell Investment Advisors sold 40 Avidity Biosciences shares in Q1 2026, an estimated $2.89K.
Bell Investment Advisors first reported a position in Avidity Biosciences in Q2 2025 and held it in 3 quarters.
Bell Investment Advisors's Avidity Biosciences position peaked at $2.89K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.